Closed · HT9425-23-NFRP-IIRA · CFDA 12.420 · Discretionary

DoD Neurofibromatosis Investigator-Initiated Award

Federal grant opportunity posted by Dept. of the Army -- USAMRAA, cataloged on Grants.gov.

Varies
Award range
Closed
Status
October 5, 2023
Close date
5
Expected awards

The verdict

DoD Neurofibromatosis Investigator-Initiated Award is a closed discretionary listing from Dept. of the Army -- USAMRAA that offered Varies by applicant across 5 expected awards. Future funding cycles may be published under the same CFDA number.

Varies
award range
Closed
application status
5
expected awards
12.420
CFDA program

Opportunity snapshot. This Grants.gov announcement - DoD Neurofibromatosis Investigator-Initiated Award - is cataloged under number HT9425-23-NFRP-IIRA and tied to CFDA assistance listing 12.420, posted by Dept. of the Army -- USAMRAA. Grants.gov currently shows the opportunity as closed, first posted on May 22, 2023 and last updated on August 10, 2023. The funding category is Discretionary, delivered as a grant.

Award economics. The award range on file is Varies by applicant. The agency has projected $4.4 million in total estimated funding for this announcement. It expects to issue 5 awards. If the agency funds the expected 5 awards from the $4.4 million estimated pool, the average award works out to roughly $888,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on October 5, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

Varies by applicant

Close Date

October 5, 2023

Posted

May 22, 2023

Est. Total Funding

$4,440,000

Expected Awards

5

Instrument

Grant

Description

The NFRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.Optional NF Open Science Initiative (NF-OSI): The FY23 NFRP supports the NF-OSI (https://www.synapse.org/#!Synapse:syn17083165/wiki/588662), which is aimed at catalyzing research for NF through early access to data and data sharing within the NF community.• The NF Data Portal (https://nf.synapse.org) is a central component of the NF-OSI and is intended as a format on which to share and explore NF datasets, analysis tools, resources, and publications. It is a public repository of raw data of scientific experiments that allows the re-analysis and confirmation of results by a third party.○ The portal is not the place to share finalized results (these are generally publishable figures and related information), but rather any data point or image derived from experiments.○ NF studies that involve generation of extensive datasets including, but not limited to, gene expression, genomic variants, methylation profiles, drug screening, drug combination screening, cellular physiology, chromatin activity, proteomics, imaging, kinomics, pharmacokinetics/pharmacodynamics, and clinical studies are to utilize the NF Data Portal.○ The portal allows participants to use the repository as their private data storage and selectively release the data to the public after an embargo period. For more information and requirements of participation, please visit https://nf.synapse.org/.• Participants in the NF-OSI will share data following the FAIR (Findable, Accessible, Interoperable, and Reusable) Data Principles for reproducible science found in “The FAIR Guiding Principles for scientific data management and stewardship” (https://www.nature.com/articles/sdata201618). Refer to the Data and Research Resources Sharing Plan document in Attachment 7.• Applications utilizing the NF-OSI option will be eligible to apply for Level 2 funding as described in below and in Section II.D.5, Funding Restrictions.• Applications utilizing the NF-OSI option must demonstrate their commitment to meeting the intent of the initiative in their Data and Research Resources Sharing Plan, including a description of milestones with respect to making the data or research resource(s) available and how they will be accessible after the period of performance expires. See Attachment 7.• Applications utilizing the NF-OSI option must describe how participation in the NF-OSI will advance and/or accelerate research in NF.• Applications funded under the NF-OSI option will need to comply with data submission requirements that meet the intent of the initiative as a condition of continued funding for their project.

Eligibility

Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org

Key Dates

Posted May 22, 2023
Close Date October 5, 2023
Archive Date November 4, 2023
Last Updated August 10, 2023

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "DoD Neurofibromatosis Investigator-Initiated Award", offered by Dept. of the Army -- USAMRAA. It is associated with CFDA program 12.420. The NFRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care. Res...
Is this opportunity still open?
No, this opportunity is closed. It closed on October 5, 2023. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is Varies by applicant. Total estimated funding: $4,440,000. Expected number of awards: 5.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants